783
Views
3
CrossRef citations to date
0
Altmetric
Review

Current Knowledge on Endometriosis Etiology: A Systematic Review of Literature

, , , , ORCID Icon, , , & show all
Pages 525-537 | Published online: 01 Jun 2021

References

  • Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519. doi:10.1016/j.fertnstert.2012.06.029
  • Viganò P, Parazzini F, Somigliana E, Vercellini P. ‘Endometriosis: epidemiology and aetiological factors’. Best Pract Res Clin Obstet Gynaecol. 2004;18:177–200. doi:10.1016/j.bpobgyn.2004.01.007
  • Browne H, Taylor H. HOXA10 expression in ectopic endometrial tissue. Fertil Steril. 2006;85(5):1386–1390. doi:10.1016/j.fertnstert.2005.10.072
  • Matsuura K, Ohtake H, Katabuchi H, Okamura H. Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest. 1999;47(Suppl.1):18–22. doi:10.1159/000052855
  • Fukunaga M, Ushigome S. Epithelial metaplastic changes in ovarian endometriosis. Modern Pathol. 1998;11(8):784–788.
  • Zheng W, Li N, Wang J, et al. Initial endometriosis showing direct morphologic evidence of metaplasia in the pathogenesis of ovarian endometriosis. Int J Gynecol Pathol. 2005;24(2):164–172. doi:10.1097/01.rct.0000157091.37057.b4
  • Mikhaleva LM, Solomatina AA, Boltovskaya MN, et al.Clinical and morphological aspects of ovarian endometriosis depending on the severity of the disease. Clin Exp Morphol. 2016;3(19):15–21.
  • Patsap OI, Tairova MB, Davydov AI, Mikhaleva LM. The role of cytological evaluation in sclerotherapy of ovarian endometrioma. Gynecol Obstet Perinatol. 2020;19(2):5–10. doi:10.20953/1726-1678-2020-2-5-10.
  • Mikhaleva LM, Davydov AI, Patsap OI, et al. Malignant transformation and associated biomarkers of ovarian endometriosis: a narrative review. Adv Ther. 2020;37:2580–2603. doi:10.1007/s12325-020-01363-5
  • Anglesio MS, Papadopoulos N, Ayhan A, et al. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 2017;376(19):1835–1848. doi:10.1056/NEJMoa1614814
  • Suda K, Nakaoka H, Yoshihara K, et al. Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium. Cell Rep. 2018;24(7):1777–1789. doi:10.1016/j.celrep.2018.07.037
  • Guo SW. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. Hum Reprod Update. 2020;26(3):423–449. doi:10.1093/humupd/dmz047
  • Zou Y, Zhou JY, Guo JB, et al. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis. Mutat Res. 2018;809:1–5. doi:10.1016/j.mrfmmm.2018.03.001
  • Suda K, Nakaoka H, Yoshihara K, et al. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium. Hum Reprod. 2019;34(10):1899–1905. doi:10.1093/humrep/dez155
  • Li X, Zhang Y, Zhao L, et al. Whole-exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes. Hum Mol Genet. 2014;23(22):6008–6021. doi:10.1093/hmg/ddu330
  • Kyo S, Sato S, Nakayama K. Cancer-associated mutations in normal human endometrium: surprise or expected? Cancer Sci. 2020;111:3458–3467. doi:10.1111/cas.14571
  • Davydov AI, Mikhaleva LM, Patsap OI. On markers of early detection of endometriosis-associated ovarian tumors. Gynecol Obstet Perinatol. 2019;4:133–137.
  • Haidarali E, Vahedi A, Mohajeri S, Mostafidi E, Azimpouran M, Naghavi Behzad M. Evaluation of the pathogenesis of tumor development from endometriosis by estrogen receptor, P53 and Bcl-2 Immunohistochemical Staining. Asian Pac J Cancer Prev. 2016;17(12):5247–5250. doi:10.22034/APJCP.2016.17.12.5247
  • Davydov AI, Mikhaleva LM, Tairova MB, Patsap OI. Ovarian endometriosis: a form of genital endometriosis or a specific nosological unit. Gynecol Obstet Perinatol. 2019;5:5–12.
  • Ramathal CY, Bagchi IC, Taylor RN, Bagchi MK. Endometrial decidualization: of mice and men. Semin Reprod Med. 2010;28(1):17–26. doi:10.1055/s-0029-1242989
  • Vasquez YM, Wu SP, Anderson ML, et al. Endometrial expression of steroidogenic factor 1 promotes cystic glandular morphogenesis. Mol Endocrinol. 2016;30(5):518–532. doi:10.1210/me.2015-1215
  • Viger RS, Guittot SM, Anttonen M, Wilson DB, Heikinheimo M. Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol Endocrinol. 2008;22(4):781–798. doi:10.1210/me.2007-0513
  • Dyson MT, Roqueiro D, Monsivais D, et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 2014;10(3):e1004158. doi:10.1371/journal.pgen.1004158
  • Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011;25(21):2227–2241. doi:10.1101/gad.176826.111
  • Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3(2):93–110.43.
  • D’Hooghe TM, Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update. 2002;8(1):84–88. doi:10.1093/humupd/8.1.84
  • Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi:10.1210/er.2018-00242
  • Missmer SA, Hankinson SE, Spiegelman D, et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol. 2004;104(5 Pt 1):965–974. doi:10.1097/01.AOG.0000142714.54857.f8
  • Izawa M, Taniguchi F, Harada T. GATA6 expression promoted by an active enhancer may become a molecular marker in endometriosis lesions. Am J Reprod Immunol. 2019;81(2):e13078. doi:10.1111/aji.13078
  • Iwafuchi-Doi M, Zaret KS. Pioneer transcription factors in cell reprogramming. Genes Dev. 2014;28(24):2679–2692. doi:10.1101/gad.253443.114
  • Marquardt RM, Kim TH, Shin JH, Jeong JW. Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis? Int J Mol Sci. 2019;20(15):3822. doi:10.3390/ijms20153822
  • Monsivais D, Dyson MT, Yin P, et al. ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. Mol Endocrinol. 2014;28(8):1304–1315. doi:10.1210/me.2013-1421
  • Lee B, Du H, Taylor HS. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod. 2009;80(1):79–85. doi:10.1095/biolreprod.108.070391
  • Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril. 2007;87(1):24–32. doi:10.1016/j.fertnstert.2006.05.077
  • Dyson MT, Kakinuma T, Pavone ME, et al. Aberrant expression and localization of deoxyribonucleic acid methyltransferase 3B in endometriotic stromal cells. Fertil Steril. 2015;104(4):953–963.e2. doi:10.1016/j.fertnstert.2015.06.046
  • Bernardi LA, Dyson MT, Tokunaga H, et al. The essential role of GATA6 in the activation of estrogen synthesis in endometriosis. Reprod Sci. 2019;26(1):60–69. doi:10.1177/1933719118756751
  • Naqvi H, Ilagan Y, Krikun G, Taylor HS. Altered genome-wide methylation in endometriosis. Reprod Sci. 2014;21(10):1237–1243. doi:10.1177/1933719114532841
  • Signorile PG, Severino A, Santoro M, Spyrou M, Viceconte R, Baldi A. Methylation analysis of HOXA10 regulatory elements in patients with endometriosis. BMC Res Notes. 2018;11(1):722. doi:10.1186/s13104-018-3836-1
  • Orazov MR, Khamoshina MB, Mikhaleva LM, et al. Molecular genetic features of the state of endometry in endometriosis-associated infertility. Difficult Patient. 2020;1–2:23–32.
  • Rubel CA, Wu SP, Lin L, et al. A Gata2-dependent transcription network regulates uterine progesterone responsiveness and endometrial function. Cell Rep. 2016;17(5):1414–1425. doi:10.1016/j.celrep.2016.09.093
  • Yang Y, Chen X, Saravelos SH, et al. HOXA-10 and E-cadherin expression in the endometrium of women with recurrent implantation failure and recurrent miscarriage. Fertil Steril. 2017;107(1):136–143.e2. doi:10.1016/j.fertnstert.2016.09.016
  • Özcan C, Özdamar Ö, Gökbayrak ME, Doğer E, Çakıroğlu Y, Çine N. HOXA-10 gene expression in ectopic and eutopic endometrium tissues: does it differ between fertile and infertile women with endometriosis? Eur J Obstet Gynecol Reprod Biol. 2019;233:43–48. doi:10.1016/j.ejogrb.2018.11.027
  • Orazov MR, Lokshin VN, Silantyeva EC, et al. Morphological and molecular biological determinants of repeated implantation failure. Bulletin of National Academy of Sciences of the Republic Of Kazakhstan. 2020;3(385):6–15. doi:10.32014/2020.2518-1467.63
  • Wang J, Huang C, Jiang R, et al. Decreased Endometrial IL-10 impairs endometrial receptivity by downregulating HOXA10 expression in women with adenomyosis. Biomed Res Int. 2018;2018:2549789. doi:10.1155/2018/2549789
  • Riyanti A, Febri RR, Zakirah SC, et al. Suppressing HOXA-10 Gene Expression by MicroRNA 135b during the window of implantation in infertile women. J Reprod Infertil. 2020;21(3):217–221.
  • Robles TG, Fernández RA, García-Palencia P, et al. Hoxa-10 and Cyclin D3 overexpression in the decidual reaction in a superovulation protocol in Young Adult C57BL/6J Mice. Vet Pathol. 2017;54(2):328–335. doi:10.1177/0300985816660748
  • Celik O, Unlu C, Otlu B, Celik N, Caliskan E. Laparoscopic endometrioma resection increases peri-implantation endometrial HOXA-10 and HOXA-11 mRNA expression. Fertil Steril. 2015;104(2):356–365. doi:10.1016/j.fertnstert.2015.04.041
  • Wu PL, Zhou Y, Zeng C, et al. Transcription factor 21 regulates expression of ERβ and SF-1 via upstream stimulatory factor-2 in endometriotic tissues. Biochim Biophys Acta Gene Regul Mech. 2018;1861(8):706–717. doi:10.1016/j.bbagrm.2018.06.008
  • Ferraz-de-souza B, Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol. 2011;336(1–2):198–205. doi:10.1016/j.mce.2010.11.006
  • Tian Y, Kong B, Zhu W, Su S, Kan Y. Expression of steroidogenic factor 1 (SF-1) and steroidogenic acute regulatory protein (StAR) in endometriosis is associated with endometriosis severity. J Int Med Res. 2009;37(5):1389–1395. doi:10.1177/147323000903700513
  • Fabbri HC, Ribeiro de Andrade JG, Maciel-Guerra AT, Guerra-Júnior G, de Mello MP. NR5A1 loss-of-function mutations lead to 46, XY partial gonadal dysgenesis phenotype: report of three novel mutations. Sex Dev. 2016;10(4):191–199. doi:10.1159/000448013
  • Attar E, Tokunaga H, Imir G, et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009;94(2):623–631. doi:10.1210/jc.2008-1180
  • Noble LS, Takayama K, Zeitoun KM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab. 1997;82(2):600–606. doi:10.1210/jcem.82.2.3783
  • Tsai SJ, Wu MH, Lin CC, Sun HS, Chen HM. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab. 2001;86(12):5765–5773. doi:10.1210/jcem.86.12.8082
  • Sun HS, Hsiao KY, Hsu CC, Wu MH, Tsai SJ. Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor. Endocrinology. 2003;144(9):3934–3942. doi:10.1210/en.2003-0289
  • Tamura M, Deb S, Sebastian S, Okamura K, Bulun SE. Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertil Steril. 2004;81(5):1351–1356. doi:10.1016/j.fertnstert.2003.09.076
  • Xue Q, Bai L, Li T, Dong Y, Zhang Y, Zhou YF.[Expression of steroidogenic factor 1 in ovarian endometriosis and adenomyosis]. Zhonghua Fu Chan Ke Za Zhi. 2011;46(11):831–833.
  • Noël JC, Anaf V, Borghese B, Vaiman D, Fayt I, Chapron C. The steroidogenic factor-1 protein is not expressed in various forms of endometriosis but is strongly present in ovarian cortical or medullary mesenchymatous cells adjacent to endometriotic foci. Fertil Steril. 2011;95(8):2655–2657. doi:10.1016/j.fertnstert.2011.01.131
  • Noël JC, Borghese B, Vaiman D, Fayt I, Anaf V, Chapron C. Steroidogenic factor-1 expression in ovarian endometriosis. Appl Immunohistochem Mol Morphol. 2010;18(3):258–261. doi:10.1097/PAI.0b013e3181c06948
  • Xue Q, Lin Z, Cheng YH, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007;77(4):681–687. doi:10.1095/biolreprod.107.061804
  • Juhasz-Böss I, Fischer C, Lattrich C, et al. Endometrial expression of estrogen receptor β and its splice variants in patients with and without endometriosis. Arch Gynecol Obstet. 2011;284(4):885–891. doi:10.1007/s00404-010-1768-7
  • Han SJ, Hawkins SM, Begum K, et al. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat Med. 2012;18(7):1102–1111. doi:10.1038/nm.2826
  • Hu X, Zhou Y, Feng Q, et al. Association of endometriosis risk and genetic polymorphisms involving biosynthesis of sex steroids and their receptors: an updating meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2012;164(1):1–9. doi:10.1016/j.ejogrb.2012.05.008
  • Bellelis P, Barbeiro DF, Rizzo LV, Baracat EC, Abrão MS, Podgaec S. Transcriptional changes in the expression of chemokines related to natural killer and T-regulatory cells in patients with deep infiltrative endometriosis. Fertil Steril. 2013;99(7):1987–1993. doi:10.1016/j.fertnstert.2013.02.038
  • Jr MH, Haddad C, Coelho G, Casoy J. Role of inflammation and aromatase expression in the eutopic endometrium and its relationship with the development of endometriosis. Womens Health (Lond). 2012;8(6):647–658. doi:10.2217/whe.12.52
  • Podgaec S, Barbeiro DF, Gueuvoghlanian-Silva BY, Bellelis P, Abrão MS, Baracat EC. Foxp3 expression in deep rectosigmoid endometriosis lesions and its association with chronic pelvic pain. J Reprod Immunol. 2014;104:96–99. doi:10.1016/j.jri.2014.05.002
  • Waiyaput W, Pumipichet S, Weerakiet S, Rattanasiri S, Sophonsritsuk A. Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial. BMC Womens Health. 2017;17(1):89. doi:10.1186/s12905-017-0446-3
  • Bellelis P, Barbeiro DF, Gueuvoghlanian-Silva BY, Kalil J, Abrão MS, Podgaec S. Interleukin-15 and interleukin-7 are the major cytokines to maintain endometriosis. Gynecol Obstet Invest. 2019;84(5):435–444. doi:10.1159/000496607
  • Gueuvoghlanian-Silva BY, Bellelis P, Barbeiro DF, Hernandes C, Podgaec S. Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease. J Reprod Immunol. 2018;126:32–38. doi:10.1016/j.jri.2018.02.003
  • Gazvani R, Templeton A. New considerations for the pathogenesis of endometriosis. Int J Gynaecol Obstet. 2002;76(2):117–126. doi:10.1016/s0020-7292(01)00577-x
  • Khan KN, Masuzaki H, Fujishita A, et al. Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis. Acta Obstet Gynecol Scand. 2006;85(4):458–466. doi:10.1080/00016340500432556
  • Rached MR, Coelho V, Marin MLC, et al. HLA-G is upregulated in advanced endometriosis. Eur J Obstet Gynecol Reproductive Biol. 2019;235:36–41. doi:10.1016/j.ejogrb.2019.01.030
  • Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol. 2013;4:9. doi:10.3389/fimmu.2013.00009
  • Braun DP, Ding J, Shen J, Rana N, Fernandez BB, Dmowski WP. Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis. Fertil Steril. 2002;78(4):830–835. doi:10.1016/s0015-0282(02)03334-4
  • Berbic M, Schulke L, Markham R, Tokushige N, Russell P, Fraser IS. Macrophage expression in endometrium of women with and without endometriosis. Hum Reprod. 2009;24(2):325–332. doi:10.1093/humrep/den393
  • Takebayashi A, Kimura F, Kishi Y, et al. Subpopulations of macrophages within eutopic endometrium of endometriosis patients. Am J Reprod Immunol. 2015;73(3):221–231. doi:10.1111/aji.12331
  • Orazov MR, Mikhaleva LM, Semenov PA. Khronicheskiy endometrit: patogenez, diagnostika, lecheniye i yego svyaz’ s besplodiyem. Klin Eksp Morfologiya. 2020;9(2):16–25. doi:10.31088/CEM2020.9.2.16-25
  • Poli-Neto OB, Meola J, Rosa-E-Silva JC, Tiezzi D. Transcriptome meta-analysis reveals differences of immune profile between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu. Sci Rep. 2020;10(1):313. doi:10.1038/s41598-019-57207-y
  • Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab. 2000;85(8):2897–2902. doi:10.1210/jcem.85.8.6739
  • Babayev SN, Park CW, Keller PW, Carr BR, Word RA, Bukulmez O. Androgens upregulate endometrial epithelial progesterone receptor expression: potential implications for endometriosis. Reprod Sci. 2017;24(10):1454‐1461. doi:10.1177/1933719117691145
  • Vasquez YM, Wang X, Wetendorf M, et al. FOXO1 regulates uterine epithelial integrity and progesterone receptor expression critical for embryo implantation. PLoS Genet. 2018;14(11):e1007787. doi:10.1371/journal.pgen.1007787
  • Marin MLC, Coelho V, Visentainer JEL, et al. Inhibitory KIR2DL2 gene: risk for deep endometriosis in euro-descendants. Reprod Sci. 2021;28(1):291–304. doi:10.1007/s43032-020-00255-x
  • Orazov MR, Ye.Orekhov R, Kamillova DP, Ye. SS. Tayny patogeneza povtornykh neudach implantatsii. Trudnyy Patsiyent. 2020;4:Tom 18. doi:10.24411/2074-1995-2020-10030
  • Dorostghoal M, Ghaffari HO, Marmazi F, Keikhah N. Overexpression of endometrial estrogen receptor-alpha in the window of implantation in women with unexplained infertility. Int J Fertil Steril. 2018;12(1):37–42. doi:10.22074/ijfs.2018.5118
  • Milesi MM, Varayoud J, Ramos JG, Luque EH. Uterine ERα epigenetic modifications are induced by the endocrine disruptor endosulfan in female rats with impaired fertility. Mol Cell Endocrinol. 2017;454:1–11. doi:10.1016/j.mce.2017.05.028
  • Camargo-Díaz F, García V, Ocampo-Bárcenas A, González-Marquez H, López-Bayghen E. Colony stimulating factor-1 and leukemia inhibitor factor expression from current-cycle cannula isolated endometrial cells are associated with increased endometrial receptivity and pregnancy. BMC Womens Health. 2017;17(1):63. doi:10.1186/s12905-017-0418-7
  • Lessey BA, Palomino WA, Apparao KB, Young SL, Lininger RA. Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women. Reprod Biol Endocrinol. 2006;4 Suppl 1(Suppl1):S9. doi:10.1186/1477-7827-4-S1-S9
  • Petousis S, Prapas Y, Margioula-Siarkou C, et al. Expression of progesterone receptors is significantly impaired in the endometrium of infertile women during the implantation window: a prospective observational study. J Matern Fetal Neonatal Med. 2016;29(23):3912–3919. doi:10.3109/14767058.2016.1152244
  • Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34(1):130–162. doi:10.1210/er.2012-1043
  • Sletten ET, Arnes M, Lyså LM, Larsen M, Ørbo A. Significance of progesterone receptors (PR-A and PR-B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study. BJOG. 2019;126(7):936–943. doi:10.1111/1471-0528.15579
  • Jackson KS, Brudney A, Hastings JM, Mavrogianis PA, Kim JJ, Fazleabas AT. The altered distribution of the steroid hormone receptors and the chaperone immunophilin FKBP52 in a baboon model of endometriosis is associated with progesterone resistance during the window of uterine receptivity. Reprod Sci. 2007;14(2):137–150. doi:10.1177/1933719106298409
  • Petousis S, Prapas Y, Margioula-Siarkou C, et al. Unexplained infertility patients present the mostly impaired levels of progesterone receptors: prospective observational study. Am J Reprod Immunol. 2018;79(6):e12828. doi:10.1111/aji.12828
  • Broi MGD, Junior RCV, Meola J, et al. Expression of PGR, HBEGF, ITGAV, ITGB3 and SPP1 genes in eutopic endometrium of infertile women with endometriosis during the implantation window: a pilot study. JBRA Assist Reprod. 2017;21(3):196–202. doi:10.5935/1518-0557.20170038
  • Kao LC, Germeyer A, Tulac S, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003;144(7):2870–2881. doi:10.1210/en.2003-0043
  • Burney RO, Talbi S, Hamilton AE, et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148(8):3814–3826. doi:10.1210/en.2006-1692
  • Osteen KG, Bruner-Tran KL, Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril. 2005;83(3):529–537. doi:10.1016/j.fertnstert.2004.11.026
  • Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril. 2019;111(2):327–340.
  • Koninckx PR, Ussia A, Tahlak M, et al. Infection as a potential cofactor in the genetic-epigenetic pathophysiology of endometriosis: a systematic review. Facts, Views Vision ObGyn. 2019;11(3):209.
  • Koninckx PR, Ussia A, Adamyan L, et al. The genetic-epigenetic pathophysiology of endometriosis: a surgeon’s view. In: Endometriosis in Adolescents. Cham: Springer; 2020:173–193.
  • Bayramova NN, Protasova AE, Raskin GA, Sobivchak MS, Yarmolinskaya MI. ‘Endometrioz-assotsiirovannyye opukholi yaichnika: morfologicheskiye i immunogistokhimicheskiye osobennosti’. Zlokachestvennyye Opukholi. 2019;9.
  • Levakov SA, Gromova TA. Prognozirovaniye retsidiva endometrioza yaichnikov i yego neoplasticheskoy transformatsii. Rossiiskii Vestnik Akushera-Ginekologa. 2019;19.
  • Gromova TA, Levakov SA. ‘Prognozirovaniye razvitiya retsidiva endometrioza yaichnikov’. Akusherstvo I Ginekologiya Sankt-Peterburga. 2019;33–39.
  • Won S, Cho YJ, Lee N, et al. Atypical endometriosis is related to a higher recurrence rate. Eur J Obstet Gynecol Reproductive Biol. 2020;254:44–51. doi:10.1016/j.ejogrb.2020.08.054
  • Kajiyama H, Suzuki S, Yoshihara M, et al. Endometriosis and cancer. Free Radic Biol Med. 2019;133:186–192. doi:10.1016/j.freeradbiomed.2018.12.015
  • Kim N, Hong SR, Lim KT, Lee KH, Kim TJ, So KA. EP886 Atypical endometriosis associated with ovarian malignancy. International Journal of Gynecological Cancer. 2019.
  • Moore L, Leongamornlert D, Coorens TH, et al. The mutational landscape of normal human endometrial epithelium. Nature. 2020;580(7805):640–646. doi:10.1038/s41586-020-2214-z
  • Lac V, Nazeran TM, Tessier‐Cloutier B, et al. Oncogenic mutations in histologically normal endometrium: the new normal? J Pathol. 2019;249(2):173–181. doi:10.1002/path.5314
  • Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016;186(4):733–747. doi:10.1016/j.ajpath.2015.11.011
  • Maeda D, Shih IM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol. 2013;20(1):45. doi:10.1097/PAP.0b013e31827bc24d